umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Patients with ulcerative colitis responding to steroid treatment up-regulate glucocorticoid receptor levels in colorectal mucosa.
Umeå University, Faculty of Medicine, Department of Clinical Sciences, Obstetrics and Gynaecology.
2008 (English)In: Journal of Crohn's & colitis, ISSN 1873-9946, Vol. 2, no 2, 123-130 p.Article in journal (Refereed) Published
Abstract [en]

Background and aims

Glucocorticosteroid treatment (GCS) is effective for attacks of ulcerative colitis (UC). However, 25–30% of patients fails to respond and may be considered steroid resistant. Glucocorticoid receptors (GR) mediate the effects of GCS. Colorectal mucosa levels of GR and NF-κB were analysed before, during and after treatment with GCS-compounds.

Methods

Patients with moderate–severe attacks of ulcerative colitis were included. Patients undergoing colonoscopy with normal finding served as controls. GR and NF-κB levels in colorectal mucosa were analysed by Western Blotting and the DNA-binding activity of NF-κB by EMSA.

Results

Twenty-eight patients and seven controls were included. Ten patients were judged clinically steroid resistant.

Responders had significantly higher levels of GR in colorectal mucosa after one week of treatment than non-responders (P = 0.039) and significantly higher levels of GR were found in responders in remission as compared to before treatment (P = 0.013). NF-κB levels did not differ between the groups at first visit. Increasing levels were found only in responders as remission was obtained (P = 0.031). EMSA detected 20% lower DNA-binding of NF-κB in responders in remission as compared to first visit (P = 0.021).

Conclusion

GR levels increase in UC-patients responding to GCS-therapy but not in steroid resistant patients and may be the reason for the lack of steroid-efficacy. Increasing NF-κB levels were found in responders attaining remission, possibly reflecting a lower turnover. A decrease in DNA-binding of NF-κB was found in these patients, perhaps because of the increased GR levels counteracting NF-κB activity.

Place, publisher, year, edition, pages
Elsevier , 2008. Vol. 2, no 2, 123-130 p.
Keyword [en]
Steroid resistance, Ulcerative colitis, Glucocorticoid receptor, NF-κB
Identifiers
URN: urn:nbn:se:umu:diva-41748DOI: 10.1016/j.crohns.2007.10.002PubMedID: 21172202OAI: oai:DiVA.org:umu-41748DiVA: diva2:407725
Available from: 2011-04-01 Created: 2011-04-01 Last updated: 2011-06-17Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Innala, Eva
By organisation
Obstetrics and Gynaecology

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 59 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf